Navigation Links
Alexza to Announce 2011 Third Quarter Financial Results on Monday, November 7, 2011
Date:10/27/2011

of central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

ADASUVE (Staccato loxapine) is Alexza's lead program, which is being developed for the acute treatment of agitation in adults with schizophrenia or bipolar disorder.  Alexza completed and announced positive results from both of its Phase 3 clinical trials and initially submitted the ADASUVE NDA in December 2009.  In October 2010, the Company received a Complete Response Letter from the FDA regarding the application.  The Company completed an end-of-review meeting with the FDA in December 2010 and a Risk Evaluation and Mitigation Strategy (REMS) guidance meeting with the FDA in April 2011.  The ADASUVE NDA was resubmitted on August 4, 2011 and has a Prescription Drug User Fee Act (PDUFA) goal date of February 4, 2012.  The ADASUVE NDA will be presented to an advisory committee on December 12, 2011.

In October 2011, the Company established a commercial partnership for ADASUVE with Grupo Ferrer International, S.A.  Grupo Ferrer is a leading pharmaceutical company in Europe with extensive operations in the Americas, and is Alexza's partner in the commercialization of ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries.  Alexza filed its ADASUVE Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) in October 2011.  

For mo
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 With herbal medicines relied ... from the U.S. Pharmacopeial Convention (USP) will provide freely ... the herbal ingredients used in these products. Today, USP ... the new Herbal Medicines Compendium ( HMC ... hmc.usp.org . HMC will ...
(Date:5/18/2013)... 18, 2013 The Open Paradigm Project, ... Occupy Psychiatry , and leading organizations in ... a social media campaign showcasing video testimonials by ... which focuses on pathology and illness rather than ... American Psychiatric Association,s (APA) rollout of its latest ...
(Date:5/17/2013)... DIEGO , May 17, 2013  Sorrento ... that its Fast-Track Advanced Technology Small Business Technology ... Institute of Allergy and Infectious Diseases (NIAID), a ... supporting the development of novel human antibody therapeutics ... aureus or Staph) infections, including methicillin-resistant ...
Breaking Medicine Technology:New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4
... 11, 2011 CardioGenics Holdings Inc. (CGNH.OB) announced today ... and CEO of CardioGenics, will be presenting at RetailInvestorConferences.com.DATE: ... This will be a live, interactive online event where ... real-time, both in the presentation hall as well as ...
... Visiting Nurse Association, a 100 year old provider ... Southeastern Massachusetts, announced that it has entered into ... home telehealth technology to patients with chronic conditions. ... developer, manufacturer and clinical service provider of award-winning ...
Cached Medicine Technology:CardioGenics Holdings Inc. to Present Live, Online at RetailInvestorConferences.com on July 12th 2Brockton Visiting Nurse Association Selects Cardiocom® Telehealth 2
(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- A child whose ... relatively higher risk for developing a respiratory infection before ... Researchers looked at data involving nearly 1,300 pairs of ... began study participation while in their first trimester of ... About 6 percent of the mothers lived within 100 ...
(Date:5/20/2013)... In celebration of National Women’s Health Week and ... The Feinstein Institute for Medical Research and ... in Science and Medicine (AWSM) , hosted its second ... business and community leaders from the region attended the ... science. , “Women face unique barriers to success ...
(Date:5/20/2013)... emergency departments play a growing role in the U.S. ... hospital admissions and serving increasingly as an advanced diagnostic ... RAND Corporation study. , While often targeted as the ... remain an important safety net for Americans who cannot ... slowing the growth of health care costs, according to ...
(Date:5/20/2013)... ANN ARBOR, Mich. As high schoolers prepare for ... a "study drug" -- a prescription stimulant or amphetamine ... University of Michigan poll shows only one in 100 ... teen has used a study drug., Study drugs refer ... attention deficit hyperactivity disorder (ADHD); commonly prescribed medicines in ...
(Date:5/20/2013)... 2013) Wolters Kluwer Health is ... Wilkins (LWW) published journals won 13 ASHPE awards ... member articles and publications for editorial, design, print ... honor to be recognized year after year for ... the industry with quality, depth, and impact," said ...
Breaking Medicine News(10 mins):Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2
... 1st, 2008 Philadelphia, PA, MORRISVILLE, Pa., June ... Chemical Dependency (ICPCD) has released its final,agenda and ... the,October 29th meeting, to be held at the ... the International Association for Pain and Chemical,Dependency., ...
... Midwest, but also in West Virginia, WASHINGTON, June ... flooding in already saturated areas of the,central United States. ... to six states in the devastated areas. Floods are ... of human hardship and,economic loss., Relief efforts are ...
... By disrupting the potassium channel of the malaria parasite, ... new malaria parasites from forming in mosquitoes and has ... tests. , By genetically altering the malaria parasite ... scientists at the University of Copenha-gen and John Hopkins ...
... superstar,Sara Evans, was presented with the national Crystal Cross ... for her work with the organization.,Evans, who has been ... 2005 was honored for the talent, time and passion ... in need. She is an award-winning singer,whose achievements include ...
... 9 Nordic Naturals, Inc., and,J.R. Carlson Laboratories, ... to dismiss the patent infringement suit entitled Nordic,Naturals, ... Inc.,filed by Nordic Naturals on May 2, 2007 ... of California. Under the terms of the stipulated,dismissal, ...
... Control Repair, Inc.,(ICR), headquartered in Warren, Michigan, received ... superior delivery of MRO Asset Management and,industrial repair ... management solutions and selling refurbished,industrial equipment to customers ... at the annual Honda of America Manufacturing,MRO Supplier ...
Cached Medicine News:Health News:8th International Conference on Pain and Chemical Dependency 2Health News:American Red Cross Responds to Floods and Tornadoes in Central United States 2Health News:American Red Cross Responds to Floods and Tornadoes in Central United States 3Health News:Researchers block transmission of malaria in animal tests 2Health News:Researchers block transmission of malaria in animal tests 3Health News:Country Music Superstar, Sara Evans, Receives Red Cross National Award 2Health News:Country Music Superstar, Sara Evans, Receives Red Cross National Award 3Health News:Country Music Superstar, Sara Evans, Receives Red Cross National Award 4Health News:Industrial Control Repair Named Honda of America Manufacturing's '2007 Supplier of the Year' 2
... Eppendorf Mastercycler Family offers fast temperature control, ... optimal flexibility. Personal cards enable safe program ... transfer of individual protocols between different Mastercyclers. ... PCR and come with a two-year warranty. ...
... The latest addition to ... thermal cyclers is the personal-sized ... ideal instrument for both basic ... It represents the culmination of ...
... well thermocycler with unique High ... for fastest available heating and ... with High Pressure Lid for ... Includes motorized lid for ...
... highest precision, more user-friendliness and absolute reliability ... the definition of the Mastercycler ep system. ... research has been developing dynamically. The same ... Systems. To keep pace with these ...
Medicine Products: